Given the significant burden of DM in today’s world, there is a growing interest in improving DM outcomes through targeted regulation of NLRP3 infalmmasome, and this study aims to facilitate further advancements in this critical field. This evidence concerns the gene NLRP3 and diabetes mellitus.